Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program

By afschroeder • October 28, 2025

Herman WH, Tyndall BD, Duru OK, Moin T, McEwen LN, Shao H, Ackermann RT, Jacobs SR, Neuwahl S, Kuo S, Zhang P, Pavkov ME, Villatoro Santos C; REALITY Network. Real-World Interventions for Type 2 Diabetes Prevention (REALITY): A Multisite Study to Assess the Effectiveness and Cost-Effectiveness of the National Diabetes Prevention Program. AJPM Focus. 2025 Jul 29;4(6):100401. doi: 10.1016/j.focus.2025.100401. PMID: 41141958; PMCID: PMC12550230.

Tags: cost-effectiveness, diabetes prevention, Endocrinology, lifestyle change programs, MOVE!, National Diabetes Prevention Program, prediabetes, Publications

Colocalization of eQTLs With Type 2 Diabetes and Glycemic Traits Using Whole-Genome Sequences in Diverse Populations From the NHLBI Trans-Omics in Precision Medicine (TOPMed) Program

Wang N, DiCorpo DA, Zhang Y, Kleinbrink E, Arnett DK, Barnard J, Blangero J, Bowden DW, Carson AP, Chen YI, Chung MK, Curran JE, Darbar[...]

Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1

Lim A, Peluso EM, Downs IA, Horwich BH, Velez-Velez MA, Lechner MG. Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome[...]

Updates in Cystic Fibrosis Related Diabetes (CFRD)

Zelada H, Kaput KL, Runchey S, Le TN. Updates in Cystic Fibrosis Related Diabetes (CFRD). Endocr Pract. 2026 Jun 9:S1530-891X(26)01031-1. doi: 10.1016/j.eprac.2026.05.038. Epub ahead of[...]